About Conference
Premier global event bringing together oncologists, oncosurgeons, researchers, and clinicians to discuss breakthroughs in oncological issues and oncological healthcare.
Highlights
The event showcases cutting-edge oncology research, novel therapies, interactive sessions, keynote talks, and networking with global leaders advancing the diagnosis, treatment, and care of oncological diseases.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
2.
Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers
3.
In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.
4.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
5.
WHO launches plan for free child cancer medicines
1.
Innovative Directions in Hematology Across Clinical Settings
2.
Transformative Approaches in Hematology for Healthcare Excellence
3.
How HLH is Revolutionizing Healthcare
4.
Essential Perspectives in Hematology and Patient Outcomes
5.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
Recommended News For You
1.
Novel Agent Effective for Cancer Wasting Disorder
2.
One-third of childhood cancer survivors experience significant fear that it could come back, study reveals
3.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
4.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
5.
According to a study, breast cancer cells work together to physically breach barriers and proliferate.
Conferences That Might Interest You
Recommended Articles For You
1.
Multidisciplinary Lessons from a Cancer of Unknown Primary
2.
Hematopoietic Stem Cell Exhaustion in Blood Disorders
3.
Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
Boost Your Knowledge With These Quizzes
1.
Quiz on Exploring Metabolic Syndrome: Understanding Risk Factors and Recent Therapeutic Advances
2.
Quiz on Heart Failure with Preserved Ejection Fraction (HFpEF): New Approaches in Treatment
3.
Quiz on Understanding the Dopamine Treatments for Parkinson's Disease Management"
4.
Quiz on Targeted Therapy vs. Chemotherapy: Understanding the Differences in Lung Cancer Treatment
5.
Quiz on Hypofractionated Radiotherapy: Revolutionizing Precision and Outcomes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge